Macro Dragon: +20,000 Confirmed Cases, +425 Deaths + Iowa Caucuses Macro Dragon: +20,000 Confirmed Cases, +425 Deaths + Iowa Caucuses Macro Dragon: +20,000 Confirmed Cases, +425 Deaths + Iowa Caucuses

Macro Dragon: +20,000 Confirmed Cases, +425 Deaths + Iowa Caucuses

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Today all about digesting latest coronavirus figures, now +20,000 cases & +425 deaths in China. We also have RBA, Iowa Causes Results & State of the Union Speech. A Bernie Sanders or Elisabeth Warren win, could derail the strong risk-on equities price action we are seeing this Tue Asia morning.

(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)



Macro Dragon: +20,000 Cases, +425 Deaths + Iowa


2019-nCoV Update Tue Asia Mrn 4 Feb…

Quick update & thoughts on the Virus since Monday check in:

  • Overall the market price action Mon in Asia was better than KVP was expected – clear tell or lack of correlation in the better than expected risk-off as China came back in, was USDCNH which continued punch up through 7 & as of this morning sits at about 7.0216 +0.11%.
  • As of this Tue Asia morning, the “official figures” are at c. 20,624 confirmed cases, +425 deaths & c. 621recovered. KVP reckons closer conservative number of infected is likely +25,000 to 50,000 on the mainland… & before its all over we are likely going to be well in the 6 figures…
  • While no doubt efforts on the ground definitely having a positive impact. Yet when you just consider that Wuhan was a home of 11m people, & that likely 5m left for the annual Lunar holiday & maybe another 1m when the countdown to the blockade was announced – given how quickly the virus seems to spread (remember unlike SARSs the 2019-nCoV spreads before the symptoms, so those temperature checks in the airport are more for aesthetics, politics & public assurance – in actuality they are not going to marginally change anything by themselves, but they do send a strong message for people to self-police their own behavior) that 20K number is just too low & one could even argue 100K is too low.
  • Out of China the countries with confirmed cases over 10 are: Japan 20, Thailand 19, Singapore 18, Hong Kong 15 (still amazing to KVP only 15 in HK), South Korea (15), Australia 12 (+2 from Mon), Germany 10 (+2 from Mon),US 11 (enters our above +10 threshold), Taiwan 10. More importantly we still only have one death out of China that was in the Philippines & linked to a Chinese individual from Wuhan.



…Iowa Causes, State of the Union, RBA & Rest of the week…

In yesterday’s Macro Dragon we covered all these points – three of which take place over the next few hours. The Iowa results are likely to be the biggest potential market mover today with a Sanders or Warren skew likely to be very bearish for US EQ & thereby RoW EQ – whilst a Biden win would be quite bullish & could overshadow the concerns around the virus for a day or so.

Bear in mind tmr we get the key ISM Non-Mfg out of the US 55.1e 55.0p. Overnight US ISM Mfg. beat very strongly 50.9a 48.5e 47.2p, with a lift up in prices as well 53.3a 52.0e 51.7p. Different day, same ol’ US outperformance vs. the RoW – again!

The coronavirus deflationary shock to China/Asia is likely only going to create a reflexivity cycle in that US outperformance vs. the RoW for the near-term. At some point we will get a China bounce (back log, stimulus, etc) – yet that could be 2Q at the earliest & may be 2H20 economically.  

From the RBA’s side, the prob of a cut has gone down to c. 20% - yet you have to think they need to take in the devasting fires into their calculus (potential lost tourism, jobs, etc. for what could be a long period), vs. now this deflationary shock. They also need to measure that vs. the paradox of MP inversely linked to FP. I.e. the more the RBA continues to do, the less pressure & lower probability of a fiscal policy response that’s needed. This is the biggest structural flaw that central bankers – especially in Europe – failed to fully grasp & likely don’t appreciate to this day. The good news for the Australians is their government balance sheet (unlike their private individuals balance sheet) is one of the least levered in the world – so plenty of room to fund some much needed fiscal policy response.



Have a fantastic wk ahead everyone, good luck on the month start, stay healthy as well as keep your mind open to profitable & abundant opportunities. Life happens for us, not to us. 




Some Anchor Pieces from #SaxoStrats:


Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.